BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liang Y, Zhao J, Zou H, Zhang J, Zhang T, Sun C. Identification of 20(S)-Ginsenoside Rh2 as a Potential EGFR Tyrosine Kinase Inhibitor. Oxidative Medicine and Cellular Longevity 2022;2022:1-11. [DOI: 10.1155/2022/6119737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Tossetta G, Marzioni D. Targeting the NRF2/KEAP1 pathway in cervical and endometrial cancers. Eur J Pharmacol 2023;941:175503. [PMID: 36641100 DOI: 10.1016/j.ejphar.2023.175503] [Reference Citation Analysis]
2 Clausse V, Fang Y, Tao D, Tagad HD, Sun H, Wang Y, Karavadhi S, Lane K, Shi Z, Vasalatiy O, Leclair CA, Eells R, Shen M, Patnaik S, Appella E, Coussens NP, Hall MD, Appella DH. Discovery of Novel Small-Molecule Scaffolds for the Inhibition and Activation of WIP1 Phosphatase from a RapidFire Mass Spectrometry High-Throughput Screen. ACS Pharmacol Transl Sci . [DOI: 10.1021/acsptsci.2c00147] [Reference Citation Analysis]